Álvarez-Nemegyei J, Negreros-Castillo A, Nuño-Gutiérrez BL, Álvarez-Berzunza J, Alcocer-Martínez LM

Language: Spanish
References: 34
Page: 395-401
PDF size: 171.26 Kb.

ABSTRACT

Background: fibromyalgia syndrome (FS) is a chronic, painful, generalized musculoskeletal disorder in which some efficacy for the conventional hypnosis modality has been claimed.
Objective: to assess the efficacy of the Ericksonian modality hypnosis in FS management.
Material and methods: forty-three FS female patients (44 ± 4.7 years old) were included. They were randomized to receive for six months: Ericksonian hypnosis (EH; 20 subjects) or a sham-hypnosis (SH; 23 subjects). Every month, patient and physician global disease assessment, tender point count and the Fibromyalgia Impact Questionnaire (FIQ) were measured.
Results: during the follow-up, we did not find inter-group differences for the rate of change related to the baseline values for the patient and physician global disease assessment and the FIQ scores. At the third month (4.0 ± 4.6 vs. 0.6 ± 3.1; p = 0.02), and at the fourth month (5.0 ± 4.6 vs. 0.8 ± 4.0; p = 0.03) of follow-up, the participants who received EH had a significant reduction of the tender point count after adjustment for patient’s age.
Conclusions: despite no effect was noted on the functional status and the patient and physician global assessment, EH produced a reduction in the number of tender points in FS. Thus, HE may be an adjuvant treatment for the management of FS patients.

REFERENCES

1. 1. Goldenberg DL. Fibromyalgia syndrome. A decade later. Arch Intern Med 1999;159:777-782.

2. 2. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-799.

3. 3. Felson DT, Goldenberg DL. The natural history of fibromyalgia. Arthritis Rheum 1986:29:1522-1526.

4. 4. Alarcín GS, Bradley LA. Advances in the treatment of fibromyalgia. Current status and future directions. Am J Med Sci 1998;315:397-404.

5. 5. Crofford LJ. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Reports 2004;6: 274-280.

6. 6. Carette S, Mc Cain GA, Bell DA, Fam AG. Evaluation of amytriptyline in primary fibrositis. A double blind placebo-controlled study. Arthritis Rheum 1986;29:1371-1377.

7. 7. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP et al. Comparison of amytriptiline, ciclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double blind-blind clinical trial. Arthritis Rheum 1994; 37:32-40.

8. 8. Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum 2004;51:9-13.

9. 9. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amytriptiline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852-1859.

10. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;112:191-197.

11. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974-2984.

12. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alpra-zolam. A double-blind, placebo controlled study. Arthritis Rheum 1991;34:552-560.

13. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003;114:537-545.

14. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-1273.

15. Volkmann H, Norregaard J, Jacobsen S, Danneskiold-Samsoe B, Knoke G, Nehrdich D. Double-blind, placebo controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibro-myalgia. Scan J Rheumatol 1997;26:206-211.

16. Bennet RM, Clark SC, Walczyck J. A randomized, double-blind, placebo controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998;104:227-231.

17. Martin L, Nutting A, McIntosh BR, Edworthy SM, Butterwick D, Cook J. An exercise training in treatment of fibromyalgia. J Rheumatol 1996;23: 1050-1053.

18. Ferraccioli G, Ghirelli L, Scita F, Nolli M, Mozzani M, Fontana S et al. EMG-biofeedback training in fibro-myalgia syndrome. J Rheumatol 1987:14:820-825.

19. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupunture in fibromyalgia: results of a controlled trial. BMJ 1992;305:1249-1252.

20. Vlaeyen JW, Teeken-Gruben NJ, Goossens ME, Rutten-van Molken MP, Pelt RA, van Eek H et al. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 1996;23:1237-1245.

21. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings. J Rheumatol 1992;19:98-103.

22. Zijlstra TR, van de Laar MA, Bernelot Moens HJ, Taal E, Zakraoui L, Rasker JJ. Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life. Rheuma-tology 2005;44:539-546.

23. Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A et al. Fibromyalgia: a randomized, controlled trial of a treatment pro-gramme based on self management. Ann Rheum Dis 2004;63:290-296.

24. Haanen HC, Hoenderdos HT, van Romunde LK, Hop WC, Mallee C, Terwiel JP et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991;18:72-75.

25. Bliss SE. Ericksonian methods: The essence of the story. En: Zeig JK, editor. Ericksonian applications in the use of the art in therapy. New York, USA: Brunner-Mazel; 1994. p. 356-366.

26. Erickson BA. Ericksonian therapy desmytified: A straightforward approach. En: Zeig JK, editor. Ericksonian applications in the use of the art in therapy. New York, USA: Brunner-Mazel; 1994. p. 147-162.

27. Hansjoerg E. Hypnosis and cancer pain: Ericksonian approach versus stardardized suggestibility testing. En: Lankton SR, Zeig JK, editor. Ericksonian monographs: Difficult context for therapy. New York, USA: Brunner-Mazel; 1995. p. 1-8.

28. Weiss FM. Ericksonian hypnotherapy for pain control during and following cancer surgery. Aust J Clin Hypnother Hypn 1993;14:53-74.

29. Messige S. Ericksonian hypnotic interventions in 10 cases of menstrual pain. Hypnosis 1991;18:217-224.

30. Williams JD. Ericksonian hypnotherapy of intractable shoulder pain. Am J Clin Hypn 1983;26:26-29.

31. Wolfe F, Smythe HA, Yunnus MB. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.

32. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-733.

33. Martínez-Rueda JO, González-Sánchez CB, Hernández-Alonzo E. Desarrollo y evaluación de la sensibilidad al cambio de una versión corta del Fibromialgia Impact Questionnaire (FIQ). Rev Mex Reumatol 1995;Supl 1:P1.

34. Lemstra M, Olszynski WP. The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trial. Clin J Pain 2005;21:166-174.